What exactly do we mean by the term "killer acquisitions," and how are those deals analyzed any differently by antitrust enforcers? In this episode, host Anant Raut talks to economist Dr. Ethel Fonseca of RBB Economics and antitrust attorney Danny Mader of Hogan Lovells LLP about how potential "killer acquisitions" get reviewed by competition agencies, using real-world examples such as Sabre/Farelogix, Visa/Plaid, and Facebook/Instagram. They explore the complexities of merger analysis, the nuances of potential competition, and how the same deal can have different outcomes in the US and the UK. With special guests: Dr. Ethel Fonseca, Partner, RBB Economics and Daniel Mader, Senior Associate, Hogan Lovells LLP Hosted by: Anant Raut